DESCRIBE <http://purl.uniprot.org/SHA-384/E55E99A12C884058881692AF8A787D5F3A14BF448663F485B8E2A6D82A56225B3CB421ADBE0B78B1D847468A69CCF87A>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/E55E99A12C884058881692AF8A787D5F3A14BF448663F485B8E2A6D82A56225B3CB421ADBE0B78B1D847468A69CCF87A	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/E55E99A12C884058881692AF8A787D5F3A14BF448663F485B8E2A6D82A56225B3CB421ADBE0B78B1D847468A69CCF87A	http://www.w3.org/2000/01/rdf-schema#comment	"This is the first study to report a group of patients with digenic familial exudative vitreoretinopathy (FEVR). In most affected eyes the stage was more severe than stage 3. We speculate that the phenotype of FEVR is more severe in patients with digenic rather than monogenic variants of FEVR-related genes."xsd:string
http://purl.uniprot.org/uniprot/#_6A7D6917706B38EBAAD3931B966A9FDAD3F0FAE8BA40CBCC10F3D58A1404220A1737EDB129FFE77203BB9BB4C6C4BD81	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/E55E99A12C884058881692AF8A787D5F3A14BF448663F485B8E2A6D82A56225B3CB421ADBE0B78B1D847468A69CCF87A
http://purl.uniprot.org/uniprot/O95859	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/E55E99A12C884058881692AF8A787D5F3A14BF448663F485B8E2A6D82A56225B3CB421ADBE0B78B1D847468A69CCF87A
http://purl.uniprot.org/uniprot/#_O95859-mappedCitation-30097784	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/E55E99A12C884058881692AF8A787D5F3A14BF448663F485B8E2A6D82A56225B3CB421ADBE0B78B1D847468A69CCF87A